-
Founded in:
2004-08-02 -
Country:
China -
Address:
No. 572, Haikou Road, Changchun Economic and Technological Development Zone -
Tax NO.:
912201011240156770 -
Registered Funds:
20 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| ANISODAMINE HYDROBROMIDE |
Anticholinergic drugs acting on M-cholinergic receptors have obvious peripheral anticholinergic effects, can relax smooth muscles, relieve microvascular spasms, and thus have antispasmodic, analgesic and microcirculatory effects. Its effect of dilating pupils and inhibiting glandular secretion is 1/20 to 1/10 of that of atropine. Because it cannot pass through the blood-brain barrier, its central effect is weaker. Compared with atropine, it has the advantages of higher selectivity and lower toxicity and side effects.
More
Anticholinergic drugs acting on M-cholinergic receptors have obvious peripheral anticholinergic effects, can relax smooth muscles, relieve microvascular spasms, and thus have antispasmodic, analgesic and microcirculatory effects. Its effect of dilating pupils and inhibiting glandular secretion is 1/20 to 1/10 of that of atropine. Because it cannot pass through the blood-brain barrier, its central effect is weaker. Compared with atropine, it has the advantages of higher selectivity and lower toxicity and side effects. |
55449-49-5 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Crude extract of polysaccharide from Rhacophora serrata |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Biofermine |
This product is a dry preparation of live enterococci, which decomposes sugars in the intestine to produce lactic acid, increasing the acidity in the intestine, thereby inhibiting the growth and reproduction of putrefactive bacteria, preventing intestinal fermentation, and reducing gas production, thus promoting digestion and stopping diarrhea.
More
This product is a dry preparation of live enterococci, which decomposes sugars in the intestine to produce lactic acid, increasing the acidity in the intestine, thereby inhibiting the growth and reproduction of putrefactive bacteria, preventing intestinal fermentation, and reducing gas production, thus promoting digestion and stopping diarrhea. |
0.15g | 0 | |
| Starch |
This product is a dry preparation of live enterococci, which decomposes sugars in the intestine to produce lactic acid, increasing the acidity in the intestine, thereby inhibiting the growth and reproduction of putrefactive bacteria, preventing intestinal fermentation, and reducing gas production, thus promoting digestion and stopping diarrhea.
More
This product is a dry preparation of live enterococci, which decomposes sugars in the intestine to produce lactic acid, increasing the acidity in the intestine, thereby inhibiting the growth and reproduction of putrefactive bacteria, preventing intestinal fermentation, and reducing gas production, thus promoting digestion and stopping diarrhea. |
9005-25-8 | 79 | |
| Powdered sugar |
This product is a dry preparation of live enterococci, which decomposes sugars in the intestine to produce lactic acid, increasing the acidity in the intestine, thereby inhibiting the growth and reproduction of putrefactive bacteria, preventing intestinal fermentation, and reducing gas production, thus promoting digestion and stopping diarrhea.
More
This product is a dry preparation of live enterococci, which decomposes sugars in the intestine to produce lactic acid, increasing the acidity in the intestine, thereby inhibiting the growth and reproduction of putrefactive bacteria, preventing intestinal fermentation, and reducing gas production, thus promoting digestion and stopping diarrhea. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Organic Calcium Boron Zinc |
Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis
More
Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis |
0 | ||
| Phosphorus |
Regulate bone metabolism, promote new bone formation, regulate calcium and phosphorus metabolism, and prevent and treat osteoporosis
More
Regulate bone metabolism, promote new bone formation, regulate calcium and phosphorus metabolism, and prevent and treat osteoporosis |
7723-14-0 | 0 | |
| Inorganic perovskite quantum dots CSPBX3 (X is CL, BR, I halogen) |
Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis
More
Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis |
0 | ||
| Inorganic salt |
This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects.
More
This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects. |
0 | ||
| Trace Elements |
This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects.
More
This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects. |
0 | ||
| L-tert-Leucine |
This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects.
More
This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects. |
20859-02-3 | 0 | |
| Active peptides for bone metabolism |
Regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, anti-inflammatory, analgesic
More
Regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, anti-inflammatory, analgesic |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 1-HYDROXY-5-OXO-5H-PYRIDO[3,2-A]PHENOXAZINE-3-CARBOXYLIC ACID MONOSODIUM SALT |
Pirenoxine sodium can competitively inhibit the effects of quinone substances on lens soluble proteins, and can also fight against cataracts caused by free radical damage to the lens, and has a certain inhibitory effect on the development of cataracts. Animal experiments have shown that pirenoxine sodium can reduce the incidence of posterior capsule opacity after extracapsular cataract extraction.
More
Pirenoxine sodium can competitively inhibit the effects of quinone substances on lens soluble proteins, and can also fight against cataracts caused by free radical damage to the lens, and has a certain inhibitory effect on the development of cataracts. Animal experiments have shown that pirenoxine sodium can reduce the incidence of posterior capsule opacity after extracapsular cataract extraction. |
51410-30-1 | 6 |